Carlsbad, CA — September 30, 2025 — Leads & Copy — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has successfully closed a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI), along with its Founder and Global Co-CEO YT Jia, President Jerry Wang, SIGN Foundation, and other investors.
FF has invested $30 million in QLGN common and preferred stock, representing approximately 55% of pro forma beneficial ownership. YT Jia has personally invested approximately $4 million, representing approximately 7% ownership.
The company plans to use the majority of the financing to establish its new crypto business, CXC10, centered on three growth engines which include six key products: C – Crypto 10 (“C10”) as Value Anchor, X – DeAI Agent (“BesTrade”), and C – RWA & Ecosystem Tokens.
As part of the investment, Jerry Wang joins as Co-CEO, YT Jia serves as Chief Advisor, and Koti Meka, CFO of FF, was appointed as CFO of QLGN.
Qualigen’s Co-CEO Kevin Richardson stated that the financing provides the capital, strategic support, and leadership required to initiate a bold transformation of the company.
Investor Relations:
ir@qlgntx.com
Source: Qualigen Therapeutics, Inc.
